CERO THERAPEUTICS HLDGS INC *W EXP 02/13/202
CERO THERAPEUTICS HLDGS INC *W EXP 02/13/202 is a security (CUSIP 71902K113) tracked across SEC portfolio filings. 3 institutional managers reported $11K on Form 13F as of 2025-06-30; 2 registered fund positions totaling $86 via N-PORT as of 2026-04-30.
Summary
- Issuer: CERO THERAPEUTICS HLDGS INC
- Class: *W EXP 02/13/202
- CUSIP: 71902K113
- Asset category: DE
- 13F holders: 3
- 13F value: $11K
- 13F period: 2025-06-30
- N-PORT fund positions: 2
- N-PORT value: $86
- N-PORT report: 2026-04-30
Top institutional holders (Form 13F)
Top fund holders (N-PORT)
| Fund | Registrant | Value | % of fund |
|---|
| Saba Capital Income & Opportunities Fund | Saba Capital Income & Opportunities Fund | $55 | 0.00% |
| Calamos Market Neutral Income Fund | CALAMOS INVESTMENT TRUST/IL | $31 | 0.00% |
More